FAQs
Can microdosing psilocybin be used to treat chronic pain?
A recent series of case studies provided promising preliminary evidence for the potential of microdosing in treating chronic pain.
Stories That Inform. Voices That Matter. Perspectives That Expand.
Explore the real-world impact of psychedelics through research updates, stories of lived experience, cultural history, tools for safety and harm reduction. Our articles are grounded in science and written with heart, so you can learn, reflect and grow.
A recent series of case studies provided promising preliminary evidence for the potential of microdosing in treating chronic pain.
At the federal level, psilocybin in listed as a Schedule I drug. The use, sale, and possession of psilocybin in
Currently, there is no empirical evidence available that supports the absorption of psychedelic compounds such as psilocybin through skin pores.
To date, there is currently limited-to-no available evidence-based knowledge on dosage method comparisons for microdosing.
Psychedelic integration is a critical component of understanding and incorporating the knowledge and lessons gained during the psychedelic experience.
For the past year, Realm of Caring, Unlimited Sciences, and Lily’s Lighthouse have been working in collaboration on an exciting
Unlimited Sciences is excited to announce the launch of a new study centered around the experiences queer people have with
Unlimited Sciences, Colorado’s leading psychedelic research nonprofit, debuts the first-of-its-kind Psychedelic Info Line.
The term for the period after a psychedelic experience, Integration is the process of reflection that can lead to action
Unlimited Sciences recently published findings from an observational psilocybin study on the health effects of psilocybin use.